share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

辉瑞 | 4:持股变动声明-高管 BOURLA ALBERT
美股sec公告 ·  08/02 11:39
Moomoo AI 已提取核心信息
Pfizer Inc. (PFE) Chairman & CEO, Albert Bourla, has been reported to engage in a transaction involving the company's stock on July 31, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and total value, have not been disclosed in the announcement. Investors are advised to monitor official filings for complete transaction details.
Pfizer Inc. (PFE) Chairman & CEO, Albert Bourla, has been reported to engage in a transaction involving the company's stock on July 31, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and total value, have not been disclosed in the announcement. Investors are advised to monitor official filings for complete transaction details.
据报道,辉瑞公司(PFE)主席兼CEO阿尔伯特·博尔拉于2024年7月31日涉嫌进行该公司股票交易。交易的具体细节,包括股份数量、股份性质、交易价格和总价值,在公告中没有透露。投资者应监控官方文件以获取完整的交易详情。
据报道,辉瑞公司(PFE)主席兼CEO阿尔伯特·博尔拉于2024年7月31日涉嫌进行该公司股票交易。交易的具体细节,包括股份数量、股份性质、交易价格和总价值,在公告中没有透露。投资者应监控官方文件以获取完整的交易详情。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息